Mauritio
Member
- Joined
- Feb 26, 2018
- Messages
- 5,669
I have posted this paragraph on another forum in May as proof that even if you use wikipedia ,arguably the most mainstream information source, as your way of learning about the vaccine ,you will read worrisome things.
Too worrisome apparently .
They removed this entire paragraph from the wikipedia page of the MRNA vaccine.
This was the original paragraph:
"Up until 2020, these mRNA biotech companies had poor results testing mRNA drugs for cardiovascular, metabolic and renal diseases; selected targets for cancer; and rare diseases like Crigler–Najjar syndrome, with most finding that the side-effects of the mRNA delivery methods were too serious.[24][25] mRNA vaccines for human use have been developed and tested for the diseases rabies, Zika, cytomegalovirus, and influenza, although these mRNA vaccines have not been licensed.[26] Many large pharmaceutical companies abandoned the technology,[24] while some biotechs re-focused on the less profitable area of vaccines, where the doses would be at lower levels and side-effects reduced.[24][27]"
This is what I think they replaced it with:
"The first human clinical trial using ex vivo dendritic cells transfected with mRNA encoding tumor antigens (therapeutic cancer mRNA vaccine) was started in 2001.[27][28] Four years later, the successful use of modified nucleosides as a method to transport mRNA inside cells without setting off the body's defense system was reported.[27][29] Clinical trial results of an mRNA vaccine directly injected into the body against cancer cells were reported in 2008.[30][31]
BioNTech in 2008 and Moderna in 2010 were founded to develop mRNA biotechnologies.[32][33] The US research agency DARPA launched at this time the biotechnology research program ADEPT to develop emerging technologies for the US military.[34][35] The agency recognized the potential of nucleic acid technology for defense against pandemics and began to invest in the field.[34] DARPA grants were seen as a vote of confidence that in turn encouraged other government agencies and private investors to invest in mRNA technology.[35] DARPA awarded at the time a $25 million grant to Moderna.[36]
The first human clinical trials using an mRNA vaccine against an infectious agent (rabies) began in 2013.[37][38] Over the next few years, clinical trials of mRNA vaccines for a number of other viruses were started. mRNA vaccines for human use have been studied for infectious agents such as influenza, Zika virus, cytomegalovirus, and Chikungunya virus.[39][40"
(mRNA vaccine - Wikipedia)
Too worrisome apparently .
They removed this entire paragraph from the wikipedia page of the MRNA vaccine.
This was the original paragraph:
"Up until 2020, these mRNA biotech companies had poor results testing mRNA drugs for cardiovascular, metabolic and renal diseases; selected targets for cancer; and rare diseases like Crigler–Najjar syndrome, with most finding that the side-effects of the mRNA delivery methods were too serious.[24][25] mRNA vaccines for human use have been developed and tested for the diseases rabies, Zika, cytomegalovirus, and influenza, although these mRNA vaccines have not been licensed.[26] Many large pharmaceutical companies abandoned the technology,[24] while some biotechs re-focused on the less profitable area of vaccines, where the doses would be at lower levels and side-effects reduced.[24][27]"
This is what I think they replaced it with:
"The first human clinical trial using ex vivo dendritic cells transfected with mRNA encoding tumor antigens (therapeutic cancer mRNA vaccine) was started in 2001.[27][28] Four years later, the successful use of modified nucleosides as a method to transport mRNA inside cells without setting off the body's defense system was reported.[27][29] Clinical trial results of an mRNA vaccine directly injected into the body against cancer cells were reported in 2008.[30][31]
BioNTech in 2008 and Moderna in 2010 were founded to develop mRNA biotechnologies.[32][33] The US research agency DARPA launched at this time the biotechnology research program ADEPT to develop emerging technologies for the US military.[34][35] The agency recognized the potential of nucleic acid technology for defense against pandemics and began to invest in the field.[34] DARPA grants were seen as a vote of confidence that in turn encouraged other government agencies and private investors to invest in mRNA technology.[35] DARPA awarded at the time a $25 million grant to Moderna.[36]
The first human clinical trials using an mRNA vaccine against an infectious agent (rabies) began in 2013.[37][38] Over the next few years, clinical trials of mRNA vaccines for a number of other viruses were started. mRNA vaccines for human use have been studied for infectious agents such as influenza, Zika virus, cytomegalovirus, and Chikungunya virus.[39][40"
(mRNA vaccine - Wikipedia)
